Mutation screening of the macrophage migration inhibitory factor gene: Positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis

Arthritis and Rheumatism

Volumn 46, Issue 9, 2002, Pages 2402-2409

  Donn, Rachelle ^a   Alourfi, Zaynab ^a   De Benedetti, Fabrizio ^b   Meazza, Cristina ^b   Zeggini, Eleftheria ^a   Lunt, Mark ^a   Stevens, Adam ^a   Shelley, Emma ^a   Lamb, Rebecca ^a   Ollier, William E R ^a   Thomson, Wendy ^a   Ray, David ^a,c   Abinun, M ^d   Becker, M ^d   Bell, A ^d   Craft, A ^d   Crawley, E ^d   David, J ^d   Foster, H ^d   Gardener Medwin, J ^d   Griffin, J ^d   Hall, A ^d   Hall, M ^d   Herrick, A ^d   Hollingworth, P ^d   Holt, L ^d   Jones, S ^d   Pountain, G ^d   Ryder, C ^d   Southwood, T ^d   Stewart, I ^d   Venning, H ^d   Wedderburn, L ^d   Woo, P ^d   Wyatt, S ^d   more..

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c Glaxo Smith Kline

^d Glaxo SmithKline ^*

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; MACROPHAGE MIGRATION INHIBITION FACTOR;

ARTHRITIS; ARTICLE; CAPILLARY ELECTROPHORESIS; CAUCASIAN; CELL LINE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EPITHELIUM CELL; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; MAJOR CLINICAL STUDY; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOBLAST; UNITED KINGDOM;

ALLELES; ARTHRITIS, JUVENILE RHEUMATOID; CELL LINE; DNA MUTATIONAL ANALYSIS; GENE FREQUENCY; GENES, REPORTER; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICROSATELLITE REPEATS; POLYMORPHISM, GENETIC; REFERENCE VALUES; TRANSFECTION;

EID: 0036746062     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10492     Document Type: Article

References (40)

1. Baugh JA, Bucala R. Macrophage migration inhibitory factor. Crit Care Med 2002;30 Suppl 1:S27-35.
2. Donnelly SC, Bucala R. Macrophage migration inhibitory factor: a regulator of glucocorticoid activity with a critical role in inflammatory disease. Mol Med Today 1997;3:502-7.
3. Lolis E. Glucocorticoid counter regulation: macrophage migration inhibitory factor as a target for drug discovery. Curr Opin Pharmacol 2001;1:662-8.
4. De Jong YP, Abadia-Molina AC, Satoskar AR, Clarke K, Rietdijk ST, Faubion WA, et al. Development of chronic colitis is dependent on the cytokine MIF. Nat Immunol 2001;2:1061-6.
5. Shimizu T, Nishihira J, Mizue Y, Nakamura H, Abe R, Watanabe H, et al. High macrophage migration inhibitory factor (MIF) serum levels associated with extended psoriasis. J Invest Dermatol 2001;116:989-90.
6. Leech M, Metz C, Hall P, Hutchinson P, Gianis K, Smith M, et al. Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum 1999;42:1601-8.
7. Repp AC, Mayhew ES, Apte S, Niederkorn JY. Human uveal melanoma cells produce macrophage migration-inhibitory factor to prevent lysis by NK cells. J Immunol 2000;165:710-15.
8. Akbar SM, Abe M, Murakami H, Tanimoto K, Kumagi T, Yamashita Y, et al. Macrophage migration inhibitory factor in hepatocellular carcinoma and liver cirrhosis: relevance to pathogenesis. Cancer Lett 2001;171:125-32.
9. Nishihira J, Ogata A. Macrophage migration inhibitory factor as a target molecule in multiple sclerosis. Curr Opin Investig Drugs 2001;2:778-82.
10. Mikulowska A, Metz CN, Bucala R, Holmdahl R. Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice. J Immunol 1997;158:5514-7.
11. Santos L, Hall P, Metz C, Bucala R, Morand EF. Role of macrophage migration inhibitory factor (MIF) in murine antigeninduced arthritis: interaction with glucocorticoids. Clin Exp Immunol 2001;123:309-14.
12. Onodera S, Kaneda K, Mizue Y, Koyama Y, Fujinaga M, Nishihira J. Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis. J Biol Chem 2000;275:444-50.
13. Onodera S, Tanji H, Suzuki K, Kaneda K, Mizue Y, Sagawa A, et al. High expression of macrophage migration inhibitory factor in the synovial tissues of rheumatoid joints. Cytokine 1999;11:163-7.
14. 2 and cyclooxygenase 2 by macrophage migration inhibitory factor. Arthritis Rheum 2001;44:1273-80.
15. Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 1998;25:1991-4.
16. Meazza C, Pignatti P, Magni-Manzoni S, Martini A, de Benedetti F. Increased levels of macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis [abstract]. Arthritis Rheum 2001;43 Suppl 9:S356.
17. Meazza C, Travaglino P, Pignatti P, Magni-Manzoni S, Ravelli A, Martini A, et al. Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis. Arthritis Rheum 2002;46:232-7.
18. Donn RP, Shelley E, Ollier WER, Thomson W, and the British Paediatric Rheumatology Study Group. A novel 5′-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2001;44:1782-5.
19. Symmons DPM, Bankhead CR, Harrison BJ, Brennan P, Barrett EM, Scott DGI, et al. Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England. Arthritis Rheum 1997;40:1955-61.
20. Paralkar V, Wistow G. Cloning the human gene for macrophage migration inhibitory factor (MIF). Genomics 1994;19:48-51.
21. Quandt K, Frech K, Karas H, Wingender E, Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 1995;23:4878-84.
22. Curtis D, Sham PC. Model-free linkage analysis using likelihoods. Am J Hum Genet 1995;57:703-16.
23. Boutellier AL, Sassone-Corsi P, Loeffler JP The protooncogene c-fos is induced by corticotropin-releasing factor and stimulates proopiomelanocortin gene transcription in pituitary cells. Mol Endocrinol 1991;5:1301-10.
24. Ray DW, Ren SG, Melmed S. Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line: role of STAT pathway. J Clin Invest 1996;97:1852-9.
25. Waeber G, Thompson N, Chautard T, Steinmann M, Nicod P, Pralong FP, et al. Transcriptional activation of the macrophage migration-inhibitory factor gene by the corticotropin-releasing factor is mediated by the cyclic adenosine 3′,5′-monophosphate responsive element-binding protein CREB in pituitary cells. Mol Endocrinol 1998;12:698-705.
26. Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 2000;275:18138-44.
27. Kay R, Doherty M, Furrie E, Sankaran D, Hutchinson I, Paterson J. Inherited haplotypes of the interleukin-10 promoter differentially regulate gene transcription [abstract]. Arthritis Rheum 1999;42 Suppl 9:S177.
28. Grom AA, Hirsch R. T-cell and T-cell receptor abnormalities in the immunopathogenesis of juvenile rheumatoid arthritis. Curr Opin Rheumatol 2000;12:420-4.
29. Wedderburn LR, Patel A, Varsani H, Woo P. Divergence in the degree of clonal expansions in inflammatory T cell subpopulations mirrors HLA-associated risk alleles in genetically and clinically distinct subtypes of childhood arthritis. Int Immunol 2001;13:1541-50.
30. Roger T, David J, Glauser MP, Calandra T. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 2001;414:920-4.
31. Mitchell RA, Liao H, Chesney J, Fingerle-Rowson G, Baugh J, David J, et al. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci U S A 2002;99:345-50.
32. Kleemann R, Hausser A, Geiger G, Mischke R, Burger-Kentischer A, Flieger O, et al. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jabl. Nature 2000;408:211-6.
33. 2 activation by macrophage migration inhibitory factor (MIF): regulatory role in cell proliferation and glucocorticoid action. J Biol Chem 1999;274:18100-6.
34. Bernhagen J, Calandra T, Mitchell RA, Martin SB, Tracey KJ, Voelter W, et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 1993;365:756-9.
35. Kats R, Metz CN, Akoum A. Macrophage migration inhibitory factor is markedly expressed in active and early-stage endometriotic lesions. J Clin Endocrinol Metab 2002;87:883-9.
36. Matsumoto K, Kanmatsuse K. Increased production of macrophage migration inhibitory factor by T cells in patients with IgA nephropathy. Am J Nephrol 2001;21:455-64.
37. Beishuizen A, Thijs LG, Haanen C, Vermes I. Macrophage migration inhibitory factor and hypothalamo-pituitary-adrenal function during critical illness. J Clin Endocrinol Metab 2001;86:2811-6.
38. Mitamura Y, Takeuchi S, Matsuda A, Tagawa Y, Mizue Y, Nishihira J. Macrophage migration inhibitory factor levels in the vitreous of patients with proliferative diabetic retinopathy. Br J Ophthalmol 2000;84:636-9.
39. Barton A, Salway F, Thomson W, Silman A, Ollier W, Worthington J, et al. MIF polymorphism is associated with susceptibility to inflammatory arthritis [abstract]. Rheumatology (Oxford) 2002;41 Suppl 1:126.
40. Amoli MM, Donn RP, Thomson W, Hajeer AH, Garcia-Porrua C, Lueiro M, et al. Macrophage migration gene polymorphism is associated with sarcoidosis in biopsy proven erythema nodosum. J Rheumatol. In press.